(Q37051052)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18176612%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

review article

1 reference

title

Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18176612%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

1 reference

stem cell transplantation

1 reference

inferred from title

United States of America

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18176612%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

author name string

F Aversa

series ordinal

1

1 reference

17 August 2017

language of work or name

English

0 references

publication date

7 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18176612%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

30 August 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18176612%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18176612%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18176612%20AND%20SRC:MED&resulttype=core&format=json

30 August 2019

page(s)

473-481

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18176612%20AND%20SRC:MED&resulttype=core&format=json

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

30 August 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Hematopoietic stem cell transplants from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Expanding the role of umbilical cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Fourth International Workshop on Haploidentical Transplants, Naples, Italy, July 8-10, 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Definition of a critical T cell threshold for prevention of GVHD after HLA non-identical PBPC transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Effect of combined T- and B-cell depletion of allogeneic HLA-mismatched bone marrow graft on the magnitude and kinetics of Epstein-Barr virus load in the peripheral blood of bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Megadose transplantation of purified peripheral blood CD34(+) progenitor cells from HLA-mismatched parental donors in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Immunobiology of exposure to non-inherited maternal antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

The influence of inherited and noninherited parental antigens on outcome after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Conditioning regimen of melphalan, fludarabine and total body irradiation in unmanipulated HLA haploidentical stem cell transplantation based on feto-maternal tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Reduced-intensity non-T-cell depleted HLA-haploidentical stem cell transplantation for older patients based on the concept of feto-maternal tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Natural killer cell alloreactivity in allogeneic hematopoietic transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Determinants of antileukemia effects of allogeneic NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

An innate view of gamma delta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Gammadelta T cells for immune therapy of patients with lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Preemptive Therapy of EBV-Related Lymphoproliferative Disease after Pediatric Haploidentical Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Immunologic potential of donor lymphocytes expressing a suicide gene for early immune reconstitution after hematopoietic T-cell-depleted stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

The potential immunogenicity of the TK suicide gene does not prevent full clinical benefit associated with the use of TK-transduced donor lymphocytes in HSCT for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Current status of haploidentical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Mesenchymal stem cells: properties and role in clinical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Cellular adoptive immunotherapy after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

CMV-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Synergistic antitumor effects of immune cell-viral biotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Transplantation of anergic histoincompatible bone marrow allografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

Allogeneic bone marrow transplantation as therapy for primary induction failure for patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Fetal-maternal microchimerism: impact on hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Immune reconstitution assessed during five years after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

NK cells: a lesson from mismatched hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the F

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021

Role and cost efficacy of unrelated cord blood in adult hematopoietic stem transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705966

7 January 2021